Blueprint Medicines (FRA:2L9) Days Payable : 137.54 (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Blueprint Medicines Days Payable?

Blueprint Medicines's average Accounts Payable for the three months ended in Mar. 2024 was €4.4 Mil. Blueprint Medicines's Cost of Goods Sold for the three months ended in Mar. 2024 was €2.9 Mil. Hence, Blueprint Medicines's Days Payable for the three months ended in Mar. 2024 was 137.54.

The historical rank and industry rank for Blueprint Medicines's Days Payable or its related term are showing as below:

FRA:2L9' s Days Payable Range Over the Past 10 Years
Min: 113.33 Med: 144.12 Max: 3934.7
Current: 291.29

During the past 11 years, Blueprint Medicines's highest Days Payable was 3934.70. The lowest was 113.33. And the median was 144.12.

FRA:2L9's Days Payable is ranked better than
66.25% of 723 companies
in the Biotechnology industry
Industry Median: 148.78 vs FRA:2L9: 291.29

Blueprint Medicines's Days Payable declined from Mar. 2023 (191.46) to Mar. 2024 (137.54). It may suggest that Blueprint Medicines accelerated paying its suppliers.

Blueprint Medicines Days Payable Historical Data

The historical data trend for Blueprint Medicines's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blueprint Medicines Days Payable Chart

Blueprint Medicines Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

4,134.23

126.10

108.00

160.69

Blueprint Medicines Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															191.46	347.04	227.00	2,069.92	137.54

Competitive Comparison of Blueprint Medicines's Days Payable

For the Biotechnology subindustry, Blueprint Medicines's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Blueprint Medicines's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Blueprint Medicines's Days Payable distribution charts can be found below:

* The bar in red indicates where Blueprint Medicines's Days Payable falls into.

Blueprint Medicines Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Blueprint Medicines's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (2.576	+	4.319)	/	2 )	/	7.831	*	365
=	3.4475					/	7.831	*	365
=	160.69

Blueprint Medicines's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (4.319	+	4.532)	/	2 )	/	2.936	*	365 / 4
=	4.4255					/	2.936	*	365 / 4
=	137.54

Blueprint Medicines Days Payable Related Terms

Thank you for viewing the detailed overview of Blueprint Medicines's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Blueprint Medicines (FRA:2L9) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Blueprint Medicines Corp (FRA:2L9) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

BPMC:USA 2L9:Germany

Address

45 Sidney Street, Cambridge, MA, USA, 02139

Website

https://www.blueprintmedicines.com

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants that are drivers of cancer and proliferative disorders. Its other drug candidate is BLU 554 FOR Advanced Hepatocellular Carcinoma, and BLU-667 for Ret Mutations, Fusions, and Predicted Resistant Mutants.

Blueprint Medicines (FRA:2L9) Headlines

No Headlines